wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35510549-6F69A358-CC7B-40E2-A3F6-2EAC5D23D5B7
Q35510549-6F69A358-CC7B-40E2-A3F6-2EAC5D23D5B7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35510549-6F69A358-CC7B-40E2-A3F6-2EAC5D23D5B7
Pilot study of bortezomib for patients with imatinib-refractory chronic myeloid leukemia in chronic or accelerated phase.
P2860
Q35510549-6F69A358-CC7B-40E2-A3F6-2EAC5D23D5B7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35510549-6F69A358-CC7B-40E2-A3F6-2EAC5D23D5B7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
313277a47e719287976523b0837978c68930e6bf
P2860
Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is active in patients with imatinib-resistant or -intolerant accelerated-phase chronic myelogenous leukemia.